1[1]Ferrier KE,Muhlmann MH,Baguet JP,et al.Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension.J Am Coll Cardiol,2002,39(6):1020-1025.
2[2]Borghi C,Prandin MG,Costa FV,et al.Use of stains and blood pressure control in hypertensive patients with hypercholesterolemia.J Cardiovase Phamacol,2000,35(4):549-555.
3[4]Stokes GS.Systolic hypertension in the elderly.Pushing the frontiers of therapy-A suggested new approach.J Clin Hypertens,2004,6 (4):192.
6[7]SHEP Cooperative Research Group.Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension.Final results of the Systolic Hypertension in the Elderly Program (SHEP).JAMA,1991,265(24):3255-3264.
9[10]Spostito AC,Mansur AP,Coelho OR,et al.Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril).Am J Cardiol,1999,83(10):1497-1499.
10[11]Danaoglu Z,Kuhursay H,Kayikcioglu M,et al.Effect of statin therapy added to ACE-inhibitors on blood pressure control and endothelial functions in hypertensive patients.Anadolu Kardiyol Derg,2003,3(4):331-337.
二级参考文献29
1Goode GK, Heagety AM. In vitro responese of human peripheral small arteries in hypercholesterolemia and effects of therapy[J].Circulation,1995,91:2898-2903.
2Panza JA, Quyyumi AA, Brush JE, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension[J].N Engl J Med,1990,323:22-27.
3Sack FM, Pfetter MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patient with average cholesterol levels[J].N Engl J Med,1996,335:1001-1009.
4Dobrucki W, Kalinowskil L. Statin-stimulated nitric oxide release from endothelium[J].Med Sci Monit,2001,7:622-627.
5Kureishi Y, Luo Z, Shiojioma I, et al. The HMG-CoA reductase inhibitor sirastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals[J].Nat Med,2000,6:1004-1010.
6Gloriose N, Troffa C, Filigheddu F, et al. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia[J].Hypertension,1999,34:1281-1286.
7Wassmann S, Laufs U, Baumer AT, et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species[J].Hypertension,2001,137:1450-1457.
8Hedblad B, Wildstraand J, Janzon L, et al. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness[J].Circulation,2001,103:1721-1726.
9Atherosclerosis research unit effect of atorvastatin on postprandial plasma lipoproteins in postinfaction patients with combined hyperlipidemia[J].Atherosclerosis,2002,162:163-170.
10Vansant G,Mertens A,Muls E.The effect of atorvastatin on postprandial lipaemia in overweight or obese women homozy gous for apoE3[J].Acta Cardiol,2001,56:149-154.
10Borghi C,Prandin MG,Costa FV,et al.Use of atains and blood pressure control in hypertensive patients with hypercholesterolemia[J].J Cardiovase Pharmacol,2000,35(4):549-555.
